RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCIE

      Supplementary nutrients for prevention of vascular calcification in patients with chronic kidney disease

      한글로보기

      https://www.riss.kr/link?id=A106171606

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract) kakao i 다국어 번역

      Vascular calcification (VC) and malnutrition associated with cardiovascular disease are common in patients with chronic kidney disease (CKD) treated with dialysis. VC, which reflects vascular aging, and malnutrition are also encountered in the non-CKD elderly population. This similarity of clinical findings suggests that the progression of CKD is related to aging and the existence of a causal relationship between VC and malnutrition. To retard renal progression, a low‑ or very‑low‑protein diet is usually recommended for CKD patients. Dietary education may induce malnutrition and deficiency of important nutrients, such as vitamins K and D. Menaquinone-7, a type of vitamin K2, is under investigation for inhibiting VC in elderly patients without CKD, as well as for prevention of VC in patients with CKD. Nutritional vitamin D, such as cholecalciferol, may be considered to decrease the required dose of active vitamin D, which increases the risk of VC due to increased calcium and phosphate loads. Omega-3 fatty acids are important nutrients and their ability to inhibit VC needs to be evaluated in clinical trials. This review focuses on the ability of supplementary nutrients to prevent VC in patients with CKD, in whom dietary restriction is essential.
      번역하기

      Vascular calcification (VC) and malnutrition associated with cardiovascular disease are common in patients with chronic kidney disease (CKD) treated with dialysis. VC, which reflects vascular aging, and malnutrition are also encountered in the non-CKD...

      Vascular calcification (VC) and malnutrition associated with cardiovascular disease are common in patients with chronic kidney disease (CKD) treated with dialysis. VC, which reflects vascular aging, and malnutrition are also encountered in the non-CKD elderly population. This similarity of clinical findings suggests that the progression of CKD is related to aging and the existence of a causal relationship between VC and malnutrition. To retard renal progression, a low‑ or very‑low‑protein diet is usually recommended for CKD patients. Dietary education may induce malnutrition and deficiency of important nutrients, such as vitamins K and D. Menaquinone-7, a type of vitamin K2, is under investigation for inhibiting VC in elderly patients without CKD, as well as for prevention of VC in patients with CKD. Nutritional vitamin D, such as cholecalciferol, may be considered to decrease the required dose of active vitamin D, which increases the risk of VC due to increased calcium and phosphate loads. Omega-3 fatty acids are important nutrients and their ability to inhibit VC needs to be evaluated in clinical trials. This review focuses on the ability of supplementary nutrients to prevent VC in patients with CKD, in whom dietary restriction is essential.

      더보기

      참고문헌 (Reference)

      1 Saifan C, "Warfarin-induced calciphylaxis : a case report and review of literature" 6 : 665-669, 2013

      2 Caluwe R, "Vitamin K2 supplementation in haemodialysis patients : a randomized dose-finding study" 29 : 1385-1390, 2014

      3 Binkley NC, "Vitamin K nutrition and osteoporosis" 125 : 1812-1821, 1995

      4 Cranenburg EC, "Vitamin K intake and status are low in hemodialysis patients" 82 : 605-610, 2012

      5 Feskanich D, "Vitamin K intake and hip fractures in women : a prospective study" 69 : 74-79, 1999

      6 Krueger T, "Vitamin K deficiency in CKD patients: a modifiable risk factor for vascular calcification?" 76 : 18-22, 2009

      7 Bancha Satirapoj, "Very low protein diet plus ketoacid analogs of essential amino acids supplement to retard chronic kidney disease progression" 대한신장학회 37 (37): 384-392, 2018

      8 Hayden MR, "Vascular ossification-calcification in metabolic syndrome, type 2 diabetes mellitus, chronic kidney disease, and calciphylaxis-calcific uremic arteriolopathy : the emerging role of sodium thiosulfate" 4 : 4-, 2005

      9 An WS, "Vascular calcification score on plain radiographs of the feet as a predictor of peripheral arterial disease in patients with chronic kidney disease" 42 : 773-780, 2010

      10 An WS, "Vascular calcification on plain radiographs is associated with carotid intima media thickness, malnutrition and cardiovascular events in dialysis patients : a prospective observational study" 14 : 27-, 2013

      1 Saifan C, "Warfarin-induced calciphylaxis : a case report and review of literature" 6 : 665-669, 2013

      2 Caluwe R, "Vitamin K2 supplementation in haemodialysis patients : a randomized dose-finding study" 29 : 1385-1390, 2014

      3 Binkley NC, "Vitamin K nutrition and osteoporosis" 125 : 1812-1821, 1995

      4 Cranenburg EC, "Vitamin K intake and status are low in hemodialysis patients" 82 : 605-610, 2012

      5 Feskanich D, "Vitamin K intake and hip fractures in women : a prospective study" 69 : 74-79, 1999

      6 Krueger T, "Vitamin K deficiency in CKD patients: a modifiable risk factor for vascular calcification?" 76 : 18-22, 2009

      7 Bancha Satirapoj, "Very low protein diet plus ketoacid analogs of essential amino acids supplement to retard chronic kidney disease progression" 대한신장학회 37 (37): 384-392, 2018

      8 Hayden MR, "Vascular ossification-calcification in metabolic syndrome, type 2 diabetes mellitus, chronic kidney disease, and calciphylaxis-calcific uremic arteriolopathy : the emerging role of sodium thiosulfate" 4 : 4-, 2005

      9 An WS, "Vascular calcification score on plain radiographs of the feet as a predictor of peripheral arterial disease in patients with chronic kidney disease" 42 : 773-780, 2010

      10 An WS, "Vascular calcification on plain radiographs is associated with carotid intima media thickness, malnutrition and cardiovascular events in dialysis patients : a prospective observational study" 14 : 27-, 2013

      11 Goodman WG, "Vascular calcification in chronic kidney disease" 43 : 572-579, 2004

      12 Vergnaud P, "Undercarboxylated osteocalcin measured with a specific immunoassay predicts hip fracture in elderly women : the EPIDOS Study" 82 : 719-724, 1997

      13 Shroff RC, "The vascular biology of calcification" 20 : 103-109, 2007

      14 Schafer C, "The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification" 112 : 357-366, 2003

      15 Nestel P, "The n-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid increase systemic arterial compliance in humans" 76 : 326-330, 2002

      16 Cranenburg EC, "The circulating inactive form of matrix Gla protein(ucMGP)as a biomarker for cardiovascular calcification" 45 : 427-436, 2008

      17 Raggi P, "The ADVANCE study : a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysis" 26 : 1327-1339, 2011

      18 Barril-Cuadrado G, "Table showing dietary phosphorus/protein ratio for the Spanish population. Usefulness in chronic kidney disease" 33 : 362-371, 2013

      19 Pilkey RM, "Subclinical vitamin K deficiency in hemodialysis patients" 49 : 432-439, 2007

      20 Hermans MM, "Study on the relationship of serum fetuin-A concentration with aortic stiffness in patients on dialysis" 21 : 1293-1299, 2006

      21 Mehta RL, "Skin necrosis associated with acquired protein C deficiency in patients with renal failure and calciphylaxis" 88 : 252-257, 1990

      22 Ogawa T, "Simple evaluation of aortic arch calcification by chest radiography in hemodialysis patients" 13 : 301-306, 2009

      23 Tamashiro M, "Significant association between the progression of coronary artery calcification and dyslipidemia in patients on chronic hemodialysis" 38 : 64-69, 2001

      24 Kovesdy CP, "Serum phosphorus and the risk of progression of chronic kidney disease" 22 : 3679-3680, 2007

      25 Kestenbaum B, "Serum phosphate levels and mortality risk among people with chronic kidney disease" 16 : 520-528, 2005

      26 Wu-Wong JR, "Role of phosphorus and vitamin D analogs in the pathogenesis of vascular calcification" 318 : 90-98, 2006

      27 Booth SL, "Response of vitamin K status to different intakes and sources of phylloquinone-rich foods : comparison of younger and older adults" 70 : 368-377, 1999

      28 Hruska KA, "Renal osteodystrophy, phosphate homeostasis, and vascular calcification" 20 : 309-315, 2007

      29 김선철, "Relationship between pulmonary hypertension, peripheral vascular calcification, and major cardiovascular events in dialysis patients" 대한신장학회 34 (34): 28-34, 2015

      30 Tonelli M, "Relation between serum phosphate level and cardiovascular event rate in people with coronary disease" 112 : 2627-2633, 2005

      31 Ok E, "Reduction of dialysate calcium level reduces progression of coronary artery calcification and improves low bone turnover in patients on hemodialysis" 27 : 2475-2486, 2016

      32 Russo D, "Pulse pressure and presence of coronary artery calcification" 4 : 316-322, 2009

      33 Noordzij M, "Progression of aortic calcification is associated with disorders of mineral metabolism and mortality in chronic dialysis patients" 26 : 1662-1669, 2011

      34 Verbeke F, "Prognostic value of aortic stiffness and calcification for cardiovascular events and mortality in dialysis patients : outcome of the calcification outcome in renal disease(CORD)study" 6 : 153-159, 2011

      35 이자영, "Pre-existing arterial pathologic changes affecting arteriovenous fistula patency and cardiovascular mortality in hemodialysis patients" 대한내과학회 32 (32): 790-797, 2017

      36 Ruiz-Gutierrez V, "Plasma lipids, erythrocyte membrane lipids and blood pressure of hypertensive women after ingestion of dietary oleic acid from two different sources" 14 : 1483-1490, 1996

      37 Mirey Karavetian, "Patient education for hyperphosphatemia management: Improving outcomes while decreasing costs?" 대한신장학회 37 (37): 4-7, 2018

      38 Block RC, "Omega-6 and trans fatty acids in blood cell membranes: a risk factor for acute coronary syndromes?" 156 : 1117-1123, 2008

      39 An WS, "Omega-3 fatty acid supplementation increases 1, 25-dihydroxyvitamin D and fetuin-A levels in dialysis patients" 32 : 495-502, 2012

      40 Block GA, "Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients" 71 : 438-441, 2007

      41 Tukaj C, "Morphological changes of aortal smooth muscle cells exposed to calcitriol in culture" 6 : 668-674, 2000

      42 Vossen LM, "Menaquinone-7 supplementation to reduce vascular calcification in patients with coronary artery disease : rationale and study protocol(VitaK-CAC Trial)" 7 : 8905-8915, 2015

      43 Shanahan CM, "Medial localization of mineralization-regulating proteins in association with Monckeberg’s sclerosis : evidence for smooth muscle cell-mediated vascular calcification" 100 : 2168-2176, 1999

      44 Amann K, "Media calcification and intima calcification are distinct entities in chronic kidney disease" 3 : 1599-1605, 2008

      45 황은아, "Management of chronic kidney disease–mineral and bone disorder: Korean working group recommendations" 대한신장학회 34 (34): 4-12, 2015

      46 Kalantar-Zadeh K, "Malnutrition-inflammation complex syndrome in dialysis patients : causes and consequences" 42 : 864-881, 2003

      47 Theuwissen E, "Lowdose menaquinone-7 supplementation improved extra-hepatic vitamin K status, but had no effect on thrombin generation in healthy subjects" 108 : 1652-1657, 2012

      48 Stenvinkel P, "Low fetuin-A levels are associated with cardiovascular death : impact of variations in the gene encoding fetuin" 67 : 2383-2392, 2005

      49 Shinaberger CS, "Longitudinal associations between dietary protein intake and survival in hemodialysis patients" 48 : 37-49, 2006

      50 Keelan PC, "Long-term prognostic value of coronary calcification detected by electron-beam computed tomography in patients undergoing coronary angiography" 104 : 412-417, 2001

      51 Fox CS, "Kidney function is inversely associated with coronary artery calcification in men and women free of cardiovascular disease : the Framingham Heart Study" 66 : 2017-2021, 2004

      52 Garneata L, "Ketoanalogue-supplemented vegetarian very low-protein diet and CKD progression" 27 : 2164-2176, 2016

      53 Kidney Disease: Improving Global Outcomes (KDIGO)CKD-MBD Work Group, "KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)" 76 (76): S1-S130, 2009

      54 Kidney Disease: Improving Global Outcomes (KDIGO)CKD-MBD Update Work Group, "KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)" 7 : 1-59, 2017

      55 Kidney Disease : Improving Global Outcomes(KDIGO)CKD Work Group, "KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease" 3 : 1-150, 2013

      56 Hirata M, "In subtotally nephrectomized rats 22-oxacalcitriol suppresses parathyroid hormone with less risk of cardiovascular calcification or deterioration of residual renal function than 1, 25(OH)2 vitamin D3" 18 : 1770-1776, 2003

      57 Kim OY, "Impact of blood or erythrocyte membrane fatty acids for disease risk prediction: focusing on cardiovascular disease and chronic kidney disease" 10 : E1454-, 2018

      58 Jung JY, "Factors associated with aortic stiffness and its change over time in peritoneal dialysis patients" 25 : 4041-4048, 2010

      59 Kanai S, "Eicosapentaenoic acid reduces warfarin-induced arterial calcification in rats" 215 : 43-51, 2011

      60 Kim SJ, "Effects of low calcium dialysate on the progression of coronary artery calcification in hemodialysis patients : an open-label 12-month randomized clinical trial" 243 : 431-436, 2017

      61 Oksa A, "Effects of longterm cholecalciferol supplementation on mineral metabolism and calciotropic hormones in chronic kidney disease" 31 : 322-329, 2008

      62 임은수, "Effects of education on low-phosphate diet and phosphate binder intake to control serum phosphate among maintenance hemodialysis patients: A randomized controlled trial" 대한신장학회 37 (37): 69-76, 2018

      63 Jwa-Kyung Kim, "Effects of Lowering Dialysate Calcium Concentrations on Arterial Stiffness in Patients Undergoing Hemodialysis" 대한내과학회 26 (26): 320-327, 2011

      64 Westenfeld R, "Effect of vitamin K2 supplementation on functional vitamin K deficiency in hemodialysis patients : a randomized trial" 59 : 186-195, 2012

      65 An WS, "Effect of omega-3 fatty acids on the modification of erythrocyte membrane fatty acid content including oleic acid in peritoneal dialysis patients" 86 : 29-34, 2012

      66 Dogan E, "Effect of depot oral cholecalciferol treatment on secondary hyperparathyroidism in stage 3 and stage 4 chronic kidney diseases patients" 30 : 407-410, 2008

      67 Schlemmer CK, "Ectopic calcification of rat aortas and kidneys is reduced with n-3fatty acid supplementation" 59 : 221-227, 1998

      68 Helvig CF, "Dysregulation of renal vitamin D metabolism in the uremic rat" 78 : 463-472, 2010

      69 Mizobuchi M, "Differential effects of vitamin D receptor activators on vascular calcification in uremic rats" 72 : 709-715, 2007

      70 Geleijnse JM, "Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease : the Rotterdam Study" 134 : 3100-3105, 2004

      71 Schurgers LJ, "Determination of phylloquinone and menaquinones in food. Effect of food matrix on circulating vitamin K concentrations" 30 : 298-307, 2000

      72 Chertow GM, "Determinants of progressive vascular calcification in haemodialysis patients" 19 : 1489-1496, 2004

      73 진동찬, "Current characteristics of dialysis therapy in Korea: 2016 registry data focusing on diabetic patients" 대한신장학회 37 (37): 20-29, 2018

      74 Russo D, "Coronary artery calcification in patients with CRF not undergoing dialysis" 44 : 1024-1030, 2004

      75 An WS, "Comparison of fatty acid contents of erythrocyte membrane in hemodialysis and peritoneal dialysis patients" 19 : 267-274, 2009

      76 Foley RN, "Clinical epidemiology of cardiovascular disease in chronic renal disease" 32 (32): S112-S119, 1998

      77 Matias PJ, "Cholecalciferol supplementation in hemodialysis patients : effects on mineral metabolism, inflammation, and cardiac dimension parameters" 5 : 905-911, 2010

      78 Garcia-Lopes MG, "Cholecalciferol supplementation in chronic kidney disease : restoration of vitamin D status and impact on parathyroid hormone" 61 : 74-82, 2012

      79 Zheng CM, "Cholecalciferol additively reduces serum parathyroid hormone levels in severe secondary hyperparathyroidism treated with calcitriol and cinacalcet among hemodialysis patients" 10 : 2018

      80 Zheng JQ, "Cholecalciferol additively reduces serum parathyroid hormone and increases vitamin D and cathelicidin levels in paricalcitol-treated secondary hyperparathyroid hemodialysis patients" 8 : E708-, 2016

      81 Cranenburg EC, "Characterisation and potential diagnostic value of circulating matrix Gla protein(MGP)species" 104 : 811-822, 2010

      82 Sokoll LJ, "Changes in serum osteocalcin, plasma phylloquinone, and urinary gamma-carboxyglutamic acid in response to altered intakes of dietary phylloquinone in human subjects" 65 : 779-784, 1997

      83 이미정, "Changes in geriatric nutritional risk index and risk of major adverse cardiac and cerebrovascular events in incident peritoneal dialysis patients" 대한신장학회 36 (36): 377-386, 2017

      84 Braam LA, "Beneficial effects of vitamins D and K on the elastic properties of the vessel wall in postmenopausal women : a follow-up study" 91 : 373-380, 2004

      85 Nishizawa Y, "Atherosclerosis in uremia : possible roles of hyperparathyroidism and intermediate density lipoprotein accumulation" 62 : S90-, 1997

      86 Shoji T, "Atherogenic lipoprotein changes in the absence of hyperlipidemia in patients with chronic renal failure treated by hemodialysis" 131 : 229-236, 1997

      87 Booth SL, "Associations between vitamin K biochemical measures and bone mineral density in men and women" 89 : 4904-4909, 2004

      88 안원석, "Associations between Oxidized LDL to LDL Ratio, HDL and Vascular Calcification in the Feet of Hemodialysis Patients" 대한의학회 24 : 115-120, 2009

      89 Shoben AB, "Association of oral calcitriol with improved survival in nondialyzed CKD" 19 : 1613-1619, 2008

      90 Kovesdy CP, "Association of activated vitamin D treatment and mortality in chronic kidney disease" 168 : 397-403, 2008

      91 Son YK, "Association between vascular calcification scores on plain radiographs and fatty acid contents of erythrocyte membrane in hemodialysis patients" 22 : 58-66, 2012

      92 Price PA, "Artery calcification in uremic rats is increased by a low protein diet and prevented by treatment with ibandronate" 70 : 1577-1583, 2006

      93 Guerin AP, "Arterial stiffening and vascular calcifications in end-stage renal disease" 15 : 1014-1021, 2000

      94 London GM, "Arterial media calcification in end-stage renal disease : impact on all-cause and cardiovascular mortality" 18 : 1731-1740, 2003

      95 Blacher J, "Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease" 38 : 938-942, 2001

      96 Nitta K, "Aortic arch calcification and clinical outcome in patients with end-stage renal disease" 223 : 79-84, 2011

      97 Paganelli F, "Altered erythrocyte n-3 fatty acids in Mediterranean patients with coronary artery disease" 78 : 27-32, 2001

      98 Lee SM, "Abdominal aortic calcification score among several vascular calcification scores of plain radiograph is the most reliable predictor of severe coronary artery calcification in dialysis patients" 39 : 729-735, 2017

      99 Honkanen E, "Abdominal aortic calcification in dialysis patients : results of the CORD study" 23 : 4009-4015, 2008

      100 Adragao T, "A simple vascular calcification score predicts cardiovascular risk in haemodialysis patients" 19 : 1480-1488, 2004

      101 Wetmore JB, "A randomized trial of cinacalcet versus vitamin D analogs as monotherapy in secondary hyperparathyroidism(PARADIGM)" 10 : 1031-1040, 2015

      102 Adragao T, "A plain X-ray vascular calcification score is associated with arterial stiffness and mortality in dialysis patients" 24 : 997-1002, 2009

      103 Hall WL, "A high-fat meal enriched with eicosapentaenoic acid reduces postprandial arterial stiffness measured by digital volume pulse analysis in healthy men" 138 : 287-291, 2008

      104 Henley C, "1, 25-Dihydroxyvitamin D3 but not cinacalcet HCl(Sensipar/Mimpara)treatment mediates aortic calcification in a rat model of secondary hyperparathyroidism" 20 : 1370-1377, 2005

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2011-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2008-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2007-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2005-01-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 1.37 0.26 1.02
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.83 0.73 0.566 0.13
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼